Navigation Links
Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
Date:10/22/2007

ionally displayed in the company's own booth (TCT Booth #2013 Level 2), as well as in the booths of several industry partners, including fixed imaging companies and stent manufacturers. GE Healthcare will exhibit their Innova IVUS integrated system live at the GE booth, and the other major fixed imaging companies including Philips, Siemens and Toshiba will all display the Volcano s5i at their respective displays to offer hands-on demonstrations and product training of this flexible IVUS system. Volcano will also participate in the CRF-sponsored "Cath lab of the Future" pavilion located at the center of the exhibit hall floor.

Comment from Management

"The rate of PCI's has dropped more than 10% over the past year in the US, yet Volcano's has seen a 28% increase in IVUS disposable revenues in the 3rd quarter of 2007 versus the same period in 2006. We believe that this indicates that interventional cardiologists may be looking to IVUS to provide more complete diagnoses and to prevent placement-related complications that are believed to contribute to stent thrombosis," said Scott Huennekens, President & CEO, of Volcano. "We expect that the ADAPT IVUS sub-study will confirm the findings of past studies, emphasizing the importance of IVUS in providing information to reduce procedural-related complications, including stent thrombosis."

About Volcano Corporation

Volcano Corporation offers a broad suite of devices that facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart diseases and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab and single-use phased array and rotational IVUS imaging catheters. Volcano also has unique advanced functionality options like VHTM IVUS tissue characterization. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guid
'/>"/>

SOURCE Volcano Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5
...al Branding Strategy, ST. LOUIS, April 30 Sigma-...tegration of its Riedel-de Haen(R),Laboratory Reag... 2008,( http://www.sigma-aldrich.com/rebranding )....e with our products and,services," said Josef Zihl... for the Research Specialties and Research Essenti...
...s,Inc. (Nasdaq: CADX ), a biopharmaceutical compa...alizing proprietary product candidates principally...that the company,s,President and CEO Theodore Schr...w at the following investment conferences:, -- D...t the InterContinental Hotel in Boston on Tues...
...mpany (NYSE: BMY ) invites investors and the gene...eting with stockholders at 10 a.m. ET on Tuesday,M...rd items to be,transacted, senior executives will ... information on how to listen to the webcast, plea...l-Myers Squibb website at, http://www.bms.com/ir ....
Other Biology Technology:Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands 2Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands 3Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008 2
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
(Date:12/2/2009)PHILADELPHIA Children exposed to secondhand cigarette smoke have an increased risk of developing lung cancer in adulthood, even if they never smoked. , Results of this study are published in Cance
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cigarette smoking increases colorectal cancer risk 2PDI Reports 2009 Second Quarter Financial Results 13399 1PDI Reports 2009 Second Quarter Financial Results 13399 2PDI Reports 2009 Second Quarter Financial Results 13399 3PDI Reports 2009 Second Quarter Financial Results 13399 4PDI Reports 2009 Second Quarter Financial Results 13399 5PDI Reports 2009 Second Quarter Financial Results 13399 6PDI Reports 2009 Second Quarter Financial Results 13399 7PDI Reports 2009 Second Quarter Financial Results 13399 8PDI Reports 2009 Second Quarter Financial Results 13399 9Orexigen 28R 29 Therapeutics to Speak at Canaccord Adams Global Growth Conference 13397 1ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12 13395 1
...st of its kind study examining the effects of meth...g appears to cause abnormal brain development in c..., 2009, online issue of Neurology , the medical j..."Methamphetamine use is an increasing problem amon...ing number of children with prenatal meth exposure...
... 2009 Immigrant women are less likely to use foli...na bifida, particularly those who recently immigra...y a St. Michael,s Hospital physician in collaborat...University of Toronto. The study is the first to p...cid use in Canada. , "Our study,s findings report...
... Cincinnati (UC) cancer cell biologists have ident...cer susceptibility and development. They say this ...position to develop lung cancer for people with a ...ther investigation, they believe the gene could be...it from earlier, more aggressive lung cancer scree...
Other Biology News:Prenatal meth exposure linked to abnormal brain development 2Immigrant women may be at higher risk of having a baby with a birth defect 2Researchers identify specific lung cancer susceptibility gene 2
...icant secondary structure are often very difficult...ittle or no product. Yield, specificity and consis...g agents in PCR amplification reactions. Polymer-A...ates., Polymer-Aide is designed for molecular bi...
MutaGEL Parodontitis from Alpco Diagnostics
... Enhancer (with betaine) substantially improves PC...specificity for amplification of many DNA template...the base-pair composition dependence of DNA meltin...s pauses of DNA polymerase, and reduces secondary ...
...strip holder is designed for use with any Costar f...ew product number, created to easily match Corning...please order under the old Sigma-Aldrich number (Z...ce. ID clarifier: "egg crate" strip holder Sterili...
Biology Products: